Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 May;33(5):771–772. doi: 10.1128/aac.33.5.771

Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates.

J E Mortensen 1, A Brumbach 1, T R Shryock 1
PMCID: PMC172531  PMID: 2751288

Abstract

Two veterinary pathogens, Bordetella bronchiseptica and Bordetella avium, were tested for their antimicrobial susceptibilities. Of the 20 antimicrobial agents tested, both species were consistently resistant to penicillin and cefuroxime but susceptible to mezlocillin, piperacillin, gentamicin, amikacin, and cefoperazone.

Full text

PDF
771

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appelbaum P. C., Tamim J., Pankuch G. A., Aber R. C. Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam. Chemotherapy. 1983;29(5):337–344. doi: 10.1159/000238217. [DOI] [PubMed] [Google Scholar]
  2. Buggy B. P., Brosius F. C., 3rd, Bogin R. M., Koller C. A., Schaberg D. R. Bordetella bronchiseptica pneumonia in a patient with chronic lymphocytic leukemia. South Med J. 1987 Sep;80(9):1187–1189. doi: 10.1097/00007611-198708090-00028. [DOI] [PubMed] [Google Scholar]
  3. Fass R. J., Barnishan J. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis. 1980 Nov-Dec;2(6):841–853. doi: 10.1093/clinids/2.6.841. [DOI] [PubMed] [Google Scholar]
  4. Fass R. J. In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila. Antimicrob Agents Chemother. 1980 Sep;18(3):483–486. doi: 10.1128/aac.18.3.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ghosh H. K., Tranter J. Bordetella bronchicanis (bronchiseptica) infection in man: review and a case report. J Clin Pathol. 1979 Jun;32(6):546–548. doi: 10.1136/jcp.32.6.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goodnow R. A. Biology of Bordetella bronchiseptica. Microbiol Rev. 1980 Dec;44(4):722–738. doi: 10.1128/mr.44.4.722-738.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kurzynski T. A., Boehm D. M., Rott-Petri J. A., Schell R. F., Allison P. E. Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project. Antimicrob Agents Chemother. 1988 Jan;32(1):137–140. doi: 10.1128/aac.32.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Papasian C. J., Downs N. J., Talley R. L., Romberger D. J., Hodges G. R. Bordetella bronchiseptica bronchitis. J Clin Microbiol. 1987 Mar;25(3):575–577. doi: 10.1128/jcm.25.3.575-577.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Saif Y. M., Moorhead P. D., Dearth R. N., Jackwood D. J. Observations on Alcaligenes faecalis infection in turkeys. Avian Dis. 1980 Jul-Sep;24(3):665–684. [PubMed] [Google Scholar]
  10. Strandberg D. A., Jorgensen J. H., Drutz D. J. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agents Chemother. 1983 Aug;24(2):282–286. doi: 10.1128/aac.24.2.282. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES